Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-04

Clinical Trial Update: Efficacy and Safety of Tenoten in the Treatment of Children With Anxiety Disorders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing efficacy and safety of Tenoten for anxiety disorders in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenoten

Snippet

Sponsor: Materia Medica Holding | Conditions: Anxiety Disorder of Childhood | Phase 4 | Status: COMPLETED